QURE uniQure NV

  1. Stocks
  2. Healthcare
  3. NASDAQ: QURE

Price (delayed)

$46.06

Market cap

$2.9B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.48

Enterprise value

$3.31B

?
Relative Growth: Rel. Growth: 17
Relative Strength: Rel. Strength: 95
Relative Valuation: Rel. Valuation: 5
Relative Profitability: Rel. Profitability: 29

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline ...

Highlights
The gross margin has soared by 68% year-on-year
The gross profit has soared by 50% YoY and by 14% from the previous quarter
The company's revenue rose by 12% QoQ but it fell by 10% YoY
The net income has declined by 5% since the previous quarter but it rose by 4% year-on-year
The equity is down by 25% QoQ
The quick ratio is down by 12% year-on-year
Sector: Healthcare
Industry: Biotechnology
Peers: AMGN BMRN

Key stats

What are the main financial stats of QURE

QURE stock price

How has the uniQure stock price performed over time
Intraday
-2.81%
1 week
-6.08%
1 month
61.44%
1 year
230.42%
YTD
92.48%
QTD
181.71%

Financial performance

How have uniQure's revenue and profit performed over time
Revenue
$18.09M
Gross profit
$16.39M
Operating income
-$191.74M
Net income
-$208.87M
Gross margin
90.6%
Net margin
-1,154.4%
The gross margin has soared by 68% year-on-year
The gross profit has soared by 50% YoY and by 14% from the previous quarter
The operating margin has contracted by 26% YoY but it has grown by 8% from the previous quarter
QURE's operating income is down by 13% YoY and by 3.4% QoQ

Price vs fundamentals

How does QURE's price correlate with its fundamentals

Growth

What is uniQure's growth rate over time

Valuation

What is uniQure stock price valuation
P/E
N/A
P/B
19.29
P/S
159.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
182.97
The company's EPS rose by 21% YoY
The equity is down by 25% QoQ
The P/S is 55% higher than the last 4 quarters average of 103.1
The company's revenue rose by 12% QoQ but it fell by 10% YoY

Efficiency

How efficient is uniQure business performance
The return on equity has surged by 70% year-on-year and by 16% since the previous quarter
The ROA has grown by 21% YoY
The return on invested capital has increased by 18% year-on-year
The company's return on sales fell by 4.2% YoY but it rose by 3.6% QoQ

Dividends

What is QURE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QURE.

Financial health

How did uniQure financials performed over time
QURE's total assets is 24% greater than its total liabilities
QURE's total assets is up by 29% year-on-year but it is down by 6% since the previous quarter
The current ratio has contracted by 13% YoY
The debt to equity has plunged by 76% YoY but it is up by 35% from the previous quarter
The equity is down by 25% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.